Article Details

EU regulator says Celltrion's COVID-19 antibody drug under real-time review

Retrieved on: 2021-02-24 18:45:00

Tags for this article:

Click the tags to see associated articles and topics

EU regulator says Celltrion's COVID-19 antibody drug under real-time review. View article details on hiswai:

Excerpt

Monoclonal antibody treatments can be synthesised in the laboratory and are already used to treat some types of cancer. The EMA said it was "too early ...

Article found on: whbl.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up